Related content

Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?

By Katsel Pavel   Li Celeste   Haroutunian Vahram  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 845-856

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies

By Arai Tetsuaki  

Acta Neuropathologica, Vol. 117, Iss. 2, 2009-02 ,pp. : 125-136

Springer Publishing Company

Access to resources Recommend Favorite

CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies

By Bibl M.   Mollenhauer B.   Esselmann H.   Lewczuk P.   Trenkwalder C.   Brechlin P.   Rüther E.   Kornhuber J.   Otto M.   Wiltfang J.  

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1771-1778

Springer Publishing Company

Access to resources Recommend Favorite

Different mechanisms of corpus callosum atrophy in Alzheimer’s disease and vascular dementia

By Tomimoto Hidekazu   Lin Jin-Xi   Matsuo Akinori   Ihara Masafumi   Ohtani Ryo   Shibata Masunari   Miki Yukio   Shibasaki Hiroshi  

Journal of Neurology, Vol. 251, Iss. 4, 2004-04 ,pp. : 398-406

Springer Publishing Company

Access to resources Recommend Favorite

Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer’s disease

By Nardone R.   Bratti A.   Tezzon F.  

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1679-1684

Springer Publishing Company

Access to resources Recommend Favorite